Intelligence Platform
Patents
Browse 29,054 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6207821
Long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for
expired patentUS 6207690
Troglitazone compounds for treating climacteric and cancer
expired patentUS 6206931
Graft prosthesis materials
expired patentUS 6207147
Cancer immunotherapy using tumor cells combined with mixed lymphocytes
expired patentUS 6207157
Conjugate vaccine for nontypeable Haemophilus influenzae
expired patentUS 6207159
Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus
expired patentUS 6207170
Patient-specific white blood cell malignancy vaccine from membrane-proteoliposomes
expired patentUS 6207186
Lamellar gels and methods for making and using
expired patentUS 6207403
Kinesin motor modulators derived from the marine sponge Adocia
expired patentUS 6207199
Process for making a particulate support matrix for making a rapidly dissolving dosage for
expired patentUS 6207412
Identification of a G protein-coupled receptor transcriptionally regulated by protein tyro
expired patentUS 6207413
Nucleic acids encoding novel orphan cytokine receptors
expired patentUS 6207416
Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic meth
expired patentUS 6207451
Mammalian muscle construct and method for producing same
expired patentUS 6203793
Compositions and methods for treating thermal injury
expired patentUS 6203778
Particulate radiopaque contrast agent for diagnostic imaging and microvascular characteriz
expired patentUS 6203787
Treating tumors using implants comprising combinations of allogeneic cells
expired patentUS 6203991
Inhibition of smooth muscle cell migration by heme oxygenase I
expired patentUS 6204000
Diagnostic methods and gene therapy using reagents derived from the human metastasis suppr
expired patentUS 6204245
Treatment of narcolepsy with immunosuppressants
expired patentUS 6204261
Inhibitors of interleukin-1.beta. Converting enzyme inhibitors
expired patentUS 6204268
Selective factor Xa inhibitors
expired patentUS 6204360
Retro-inverso thymosin alpha 1 hybrids
expired patentUS 6200558
Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorpor
expired